skip to Main Content
Swell Farmacy Rebrands as Curaleaf; Joins Leading National Network of 28 Dispensaries Operating across the County


Curaleaf to host four days of Grand Opening celebrations with all attendees eligible for a “First Time Patient Special”

Four Swell Farmacy medical cannabis dispensaries located in the Metro Phoenix area have been rebranded under the Curaleaf name. Curaleaf, Inc. is a vertically integrated cannabis operator that owns and operates a network of 28 dispensaries across 12 states. Curaleaf sets the standard for safety, reliability and quality within the cannabis industry and is a trusted provider of premium cannabis products. Curaleaf acquired the four Swell Farmacy dispensaries in April of 2018.
The thousands of daily patients who rely on Swell Farmacy’s exemplary customer care and range of products will see no changes to their current experience and will instead be able to take advantage of an expanded product line that will now include a range of Curaleaf branded products, including vape cartridges, vape slims and more.

To celebrate the rebrand, Curaleaf is hosting Grand Opening celebrations at all four locations.

Each celebration will include prizes, giveaways, discounts, education opportunities, and free tacos.

All Swell patients and any new patients who walk in the door are eligible to receive Curaleaf’s First Time Patient Special, which offers “Buy One, Get One Free” (BOGO) discounts on flower (up to 1/4 oz), Swell-branded concentrate (up to two grams), and certain vendor products.

“Since opening our first location in 2013, we have developed deep relationships with patients in Arizona who rely on and trust our medical cannabis,” said Steve Cottrell, Curaleaf Arizona president. “Swell is known for its welcoming dispensaries, knowledgeable and compassionate staff, quality products, and special offers. None of that will change under Curaleaf, but the acquisition enables us to provide even more resources to help this community.”

About Curaleaf

Curaleaf is a leading vertically integrated cannabis operator in the United States. Headquartered in Wakefield, Massachusetts, Curaleaf has a presence in 12 states, owns and operates 28 dispensaries, 12 cultivation sites and nine processing sites with a focus on highly populated, limited license states, including Florida, Massachusetts, New Jersey and New York. Curaleaf leverages its extensive research and development capabilities to distribute cannabis products in multiple formats with the highest standard for safety, effectiveness, consistent quality and customer care. Curaleaf is committed to being the industry’s leading resource in education and advancement through research and advocacy. More information regarding Curaleaf can be found at


For Curaleaf
Samantha Qualls, 212-889-0808
[email protected]

This Post Has 0 Comments

Leave a Reply

Your email address will not be published.

Recent Stories

NY’s medical marijuana patients frustrated as home-grow rules remain elusive

As the gears of the state’s rule-making process grind slowly forward, frustration and impatience best describe the feelings of New Yorkers who rely on cannabis as medicine. While the Office of Cannabis Management continues to assess the latest round of public comments on proposed rules governing personal cultivation by medical patients, a trio of such patients recently offered their experiences…

Bi-Annual Cannabis Event MJ Unpacked Announces the Debut of the MJU Venture Summit

PRESS RELEASE The event will be exclusively available to venture fund managers, family office executives and UHNW individuals, featuring speakers from leaders in the cannabis industry Las Vegas, August 11, 2022 – Recently dubbed the cannabis industry’s most inventive conference, MJ Unpacked announced the launch of the MJU Venture Summit to be held on Wednesday,…

Pot legalization measure will appear on November ballot in North Dakota

A measure to legalize recreational marijuana for adults will appear on the Nov. 8 ballot in North Dakota after clearing a final hurdle. Secretary of State Al Jaeger announced on Monday, Aug. 15, that his office validated more than 23,000 signed petitions turned in by the pro-legalization sponsoring group — well over the 15,582 signature…

How Cannabis Companies Can Avoid Lawsuits and Scrutiny with Accurate Lab Testing

By Roger Brown The enduring federal cannabis ban means cannabis companies have no national testing rules, standardization, or guidelines to follow. To make matters worse, states lack oversight mechanisms to check label accuracy and weed out bad actors efficiently. These compliance gaps, combined with the market’s misguided focus on selling unrealistically and inaccurately “high-THC strains.”…

More Categories

Back To Top
×Close search